Rhumbline Advisers lifted its stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Free Report) by 4.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 253,037 shares of the company’s stock after purchasing an additional 11,033 shares during the period. Rhumbline Advisers owned about 0.27% of Acadia Healthcare worth $10,033,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Wellington Management Group LLP boosted its stake in shares of Acadia Healthcare by 12.2% in the 3rd quarter. Wellington Management Group LLP now owns 11,658,253 shares of the company’s stock valued at $739,250,000 after buying an additional 1,266,384 shares during the period. JPMorgan Chase & Co. lifted its stake in Acadia Healthcare by 17.0% in the third quarter. JPMorgan Chase & Co. now owns 3,126,607 shares of the company’s stock worth $198,258,000 after acquiring an additional 454,044 shares during the last quarter. State Street Corp grew its holdings in Acadia Healthcare by 3.5% during the 3rd quarter. State Street Corp now owns 2,819,911 shares of the company’s stock worth $178,811,000 after acquiring an additional 95,613 shares in the last quarter. Point72 Asset Management L.P. increased its position in shares of Acadia Healthcare by 0.5% in the 3rd quarter. Point72 Asset Management L.P. now owns 2,282,810 shares of the company’s stock valued at $144,753,000 after purchasing an additional 12,470 shares during the last quarter. Finally, Geode Capital Management LLC raised its holdings in shares of Acadia Healthcare by 0.9% in the 3rd quarter. Geode Capital Management LLC now owns 1,613,198 shares of the company’s stock valued at $102,320,000 after purchasing an additional 14,197 shares in the last quarter.
Acadia Healthcare Stock Up 2.6 %
Shares of NASDAQ:ACHC opened at $40.67 on Tuesday. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07. The stock has a market cap of $3.78 billion, a P/E ratio of 13.33, a P/E/G ratio of 1.50 and a beta of 1.30. Acadia Healthcare Company, Inc. has a 1-year low of $36.50 and a 1-year high of $87.77. The firm has a fifty day moving average price of $42.13 and a 200 day moving average price of $52.59.
Wall Street Analyst Weigh In
Read Our Latest Analysis on Acadia Healthcare
About Acadia Healthcare
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Featured Articles
- Five stocks we like better than Acadia Healthcare
- Earnings Per Share Calculator: How to Calculate EPS
- Finding Hidden Gems: Unconventional Penny Stock Investing
- The 3 Best Blue-Chip Stocks to Buy Now
- Price Targets on NVIDIA Rise in Front of Earnings
- Should You Invest in Penny Stocks?
- Archer Aviation Stock Skids: Mistaking Progress for Bad News?
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.